Impact of Protein Modification on the Protein Corona on Nanoparticles and Nanoparticle–Cell Interactions
Source abstract
Abstract
Recent studies have firmly established that cellular uptake of nanoparticles is strongly affected by the presence and the physicochemical properties of a protein adsorption layer around these nanoparticles. Here, we have modified human serum albumin (HSA), a serum protein often used in model studies of protein adsorption onto nanoparticles, to alter its surface charge distribution and investigated the consequences for protein corona formation around small (radius ∼5 nm), dihydrolipoic acid-coated quantum dots (DHLA-QDs) by using fluorescence correlation spectroscopy. HSA modified by succinic anhydride (HSAsuc) to generate additional carboxyl groups on the protein surface showed a 3-fold decreased binding affinity toward the nanoparticles. A 1000-fold enhanced affinity was observed for HSA modified by ethylenediamine (HSAam) to increase the number of amino functions on the protein surface. Remarkably, HSAsuc formed a much thicker protein adsorption layer (8.1 nm) than native HSA (3.3 nm), indicating that it binds in a distinctly different orientation on the nanoparticle, whereas the HSAam corona (4.6 nm) is only slightly thicker. Notably, protein binding to DHLA-QDs was found to be entirely reversible, independent of the modification. We have also measured the extent and kinetics of internalization of these nanoparticles without and with adsorbed native and modified HSA by HeLa cells. Pronounced variations were observed, indicating that even small physicochemical changes of the protein corona may affect biological responses.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Protein Interaction Studies and Fluorescence Analysis · Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Applied Physics and Center for Functional Nanostructures (CFN), Karlsruhe Institute of Technology (KIT), 76128 Karlsruhe, Germany
Institute of Physical Chemistry, University of Duisburg-Essen, 45141 Essen, Germany
Fraunhofer ICT-IMM, 55129 Mainz, Germany
Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States
Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany
References (85)
Show source-provided references
1. Treuel L. · J. R. Soc. Interface · 2013 · 10 · 174210.1098/rsif.2012.0939 ↗
2. Lunov O. · Biomaterials · 2010 · 31 · 901510.1016/j.biomaterials.2010.08.003 ↗
3. Asha Rani P. V. · ACS Nano · 2008 · 3 · 27910.1021/nn800596w ↗
4. de Paoli Lacerda S. H. · ACS Nano · 2010 · 4 · 36510.1021/nn9011187 ↗
5. Cedervall T. · Angew. Chem., Int. Ed. · 2007 · 46 · 575410.1002/anie.200700465 ↗
6. Cedervall T. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 205010.1073/pnas.0608582104 ↗
7. Lundqvist M. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1426510.1073/pnas.0805135105 ↗
8. Röcker C. · Nat. Nanotechnol. · 2009 · 4 · 57710.1038/nnano.2009.195 ↗
9. Treuel L. · ChemPhysChem · 2010 · 11 · 309310.1002/cphc.201000174 ↗
10. Klein J. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 202910.1073/pnas.0611610104 ↗
11. Leszczynski J. · Nat. Nanotechnol. · 2010 · 5 · 63310.1038/nnano.2010.182 ↗
12. Monopoli M. P. · J. Am. Chem. Soc. · 2011 · 133 · 252510.1021/ja107583h ↗
13. Frauenfelder H. · Ber. Bunsen-Ges. Phys. Chem. · 1991 · 95 · 27210.1002/bbpc.19910950310 ↗
14. Aubin-Tam M.-E. · Langmuir · 2005 · 21 · 1208010.1021/la052102e ↗
15. Roach P. · J. Am. Chem. Soc. · 2006 · 128 · 393910.1021/ja056278e ↗
16. Medintz I. L. · Proc. Natl. Acad. Sci. U.S.A. · 2004 · 101 · 961210.1073/pnas.0403343101 ↗
17. Vertegel A. A. · Langmuir · 2004 · 20 · 680010.1021/la0497200 ↗
18. Rodriguez C. E. · Chem.–Biol. Interact. · 2005 · 155 · 9710.1016/j.cbi.2005.05.002 ↗
19. Lynch I. · Science STKE · 2006 · 2006 · pe1410.1126/stke.3272006pe14 ↗
20. Baron M. H. · J. Colloid Interface Sci. · 1999 · 214 · 31910.1006/jcis.1999.6189 ↗
21. Brandes N. · J. Colloid Interface Sci. · 2006 · 299 · 5610.1016/j.jcis.2006.01.065 ↗
22. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
23. des Rieux A. · J. Controlled Release · 2006 · 116 · 110.1016/j.jconrel.2006.08.013 ↗
24. Yan M. · Nat. Nanotechnol. · 2009 · 5 · 4810.1038/nnano.2009.341 ↗
25. Liu L. · Nat. Nanotechnol. · 2009 · 4 · 45710.1038/nnano.2009.153 ↗
26. Nel A. · Science · 2006 · 311 · 62210.1126/science.1114397 ↗
27. Kostarelos K. · Nat. Nanotechnol. · 2009 · 4 · 62710.1038/nnano.2009.241 ↗
28. Tasis D. · Chem. Rev. · 2006 · 106 · 110510.1021/cr050569o ↗
29. Hamman J. H. · BioDrugs · 2005 · 19 · 16510.2165/00063030-200519030-00003 ↗
30. Galindo-Rodriguez S. A. · Crit. Rev. Ther. Drug Carrier Syst. · 2005 · 22 · 41910.1615/CritRevTherDrugCarrierSyst.v22.i5.10 ↗
31. Ghosh P. · Adv. Drug Delivery Rev. · 2008 · 60 · 130710.1016/j.addr.2008.03.016 ↗
32. Gan Z. H. · Polymer · 1999 · 40 · 285910.1016/S0032-3861(98)00549-7 ↗
33. Leroueil-Le V. M. · Eur. J. Pharm. Biopharm. · 1998 · 46 · 13710.1016/S0939-6411(98)00015-0 ↗
34. Balthasar S. · Biomaterials · 2005 · 26 · 272310.1016/j.biomaterials.2004.07.047 ↗
35. Johnson F. A. · J. Pharm. Pharmacol. · 1997 · 49 · 63910.1111/j.2042-7158.1997.tb06085.x ↗
36. Fonseca C. · J. Controlled Release · 2002 · 83 · 27310.1016/S0168-3659(02)00212-2 ↗
37. Kumar Ravi M. N. · Biomaterials · 2004 · 25 · 177110.1016/j.biomaterials.2003.08.069 ↗
38. Dillen K. · Int. J. Pharm. · 2004 · 275 · 17110.1016/j.ijpharm.2004.01.033 ↗
39. Govender T. · J. Controlled Release · 1999 · 57 · 17110.1016/S0168-3659(98)00116-3 ↗
40. Lemoine D. · J. Controlled Release · 1998 · 54 · 1510.1016/S0168-3659(97)00241-1 ↗
41. Langer R. S. · Biomaterials · 1981 · 2 · 20110.1016/0142-9612(81)90059-4 ↗
42. Miller J. D. · Adv. Drug Delivery Rev. · 1997 · 60 · 179
43. Ayalasomayajula S. P. · Eur. J. Pharm. Biopharm. · 2005 · 511 · 19110.1016/j.ejphar.2005.02.019 ↗
44. Kou J. H. · J. Controlled Release · 1997 · 43 · 12310.1016/S0168-3659(96)01477-0 ↗
45. Lee S. Y. · Biomaterials · 2003 · 24 · 504910.1016/S0142-9612(03)00411-3 ↗
46. Zhou T. · J. Controlled Release · 1998 · 55 · 28110.1016/S0168-3659(98)00061-3 ↗
47. Maffre P. · Beilstein J. Nanotechnol. · 2011 · 2 · 37410.3762/bjnano.2.43 ↗
48. He X. M. · Nature · 1992 · 358 · 20910.1038/358209a0 ↗
49. Dolinsky T. J. · Nucleic Acids Res. · 2004 · 32 · W66510.1093/nar/gkh381 ↗
50. Habeeb A. F. S. · J. Immunol. · 1967 · 99 · 126410.4049/jimmunol.99.6.1264 ↗
51. Jansen R. W. · Mol. Pharmacol. · 1993 · 44 · 100310.1016/S0026-895X(25)13254-9 ↗
52. Hermanson, G. T.Bioconjugate Techniques;Academic Press:San Diego, CA, 1996; p785.
53. Aitken A. · 1996 · 34310.1007/978-1-60327-259-9_53 ↗
54. Lamb D. C. · Biophys. J. · 2000 · 79 · 112910.1016/S0006-3495(00)76366-1 ↗
55. Maiti S. · Proc. Natl. Acad. Sci. U.S.A. · 1997 · 94 · 1175310.1073/pnas.94.22.11753 ↗
56. Zemanová L. · Drug Discovery Today · 2003 · 8 · 108510.1016/S1359-6446(03)02833-2 ↗
57. Treuel L. · Biophys. Rev. · 2012 · 4 · 13710.1007/s12551-012-0072-0 ↗
58. Jiang X. · ACS Nano · 2010 · 4 · 678710.1021/nn101277w ↗
59. Jiang X. · Biomacromolecules · 2010 · 11 · 74810.1021/bm901348z ↗
60. Jiang X. · Nanoscale · 2011 · 3 · 202810.1039/c0nr00944j ↗
61. Wang T. · ACS Nano · 2012 · 6 · 125110.1021/nn203892h ↗
62. Jiang X. · J. R. Soc. Interface · 2010 · 7 · S5
63. Salvati A. · Nat, Nanotechnol. · 2013 · 8 · 13710.1038/nnano.2012.237 ↗
64. Lesniak A. · J. Am. Chem. Soc. · 2013 · 135 · 143810.1021/ja309812z ↗
65. Lesniak A. · ACS Nano · 2012 · 6 · 584510.1021/nn300223w ↗
66. Shang L. · Nano Res. · 2012 · 5 · 53110.1007/s12274-012-0238-x ↗
67. Lunov O. · ACS Nano · 2011 · 5 · 165710.1021/nn2000756 ↗
68. Patel P. C. · Bioconjugate Chem. · 2010 · 21 · 225010.1021/bc1002423 ↗
69. Lunov O. · Biomaterials · 2011 · 32 · 54710.1016/j.biomaterials.2010.08.111 ↗
70. Yang L. · Nanoscale · 2013 · 5 · 153710.1039/c2nr33147k ↗
71. Roser M. · Eur. J. Pharm. Biopharm. · 1998 · 46 · 25510.1016/S0939-6411(98)00038-1 ↗
72. Aggarwal P. · Adv. Drug Delivery Rev. · 2009 · 61 · 42810.1016/j.addr.2009.03.009 ↗
73. Owens D. E. · Int. J. Pharm. · 2006 · 307 · 9310.1016/j.ijpharm.2005.10.010 ↗
74. Tenzer S. · ACS Nano · 2011 · 5 · 715510.1021/nn201950e ↗
75. Brancolini G. · ACS Nano · 2012 · 6 · 986310.1021/nn303444b ↗
76. Gebauer J. S. · Langmuir · 2012 · 28 · 967310.1021/la301104a ↗
77. Treuel L. · J. Nanopart. Res. · 2012 · 14 · 110.1007/s11051-012-1102-3 ↗
78. Breus V. V. · ACS Nano · 2009 · 3 · 257310.1021/nn900600w ↗
79. Clapp A. R. · Nat. Protocols · 2006 · 1 · 125810.1038/nprot.2006.184 ↗
80. 10.1002/admi.20130007910.1002/admi.201300079 ↗
81. Heyes C. D. · J. Phys. Chem. B · 2004 · 108 · 1338710.1021/jp049057o ↗
82. Kobitski A. Y. · Angew. Chem., Int. Ed. · 2008 · 47 · 432610.1002/anie.200705675 ↗
83. Müller C. B. · Europhys. Lett. · 2008 · 83 · 4600110.1209/0295-5075/83/46001 ↗
84. Shang L. · Nanoscale · 2012 · 4 · 415510.1039/c2nr30219e ↗
85. Chenyang X. · IEEE Trans. Image Process. · 1998 · 7 · 35910.1109/83.661186 ↗